Cambridge, UK and Marlborough, MA, 28 May 2025: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, has announced a ...

Creative Biolabs announces upgraded downstream services designed to bridge the gap between raw antibody expression and ...

Cholesterol oxidase is a microbial enzyme that catalyses the oxidation of cholesterol into cholestenone, a reaction pivotal to both clinical diagnostics and diverse industrial bioconversions. Over ...

Nuclera agreed to collaborate with Cytiva to focus on accelerating the production, purification, and characterization of proteins needed for pharma R&D. The collaboration will work with Nuclera’s ...